Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ole Rasmus Ødegård"'
Publikováno v:
Scandinavian Journal of Haematology. 17:258-262
Heparin cofactor activity and antithrombin III (At-III) concentration were measured in plasma from 219 healthy men and 177 women. Narrow ranges for heparin cofactor activity and At-III concentration were found. The standard deviation for heparin cofa
Autor:
Ulrich Abildgaard, Ole Rasmus Ødegård
Publikováno v:
Scandinavian Journal of Haematology. 18:86-90
Antithrombin III (At-III) concentration and amidolytic assays reflecting functions of the At-III molecule were studied in members of a family with a strong tendency to thrombosis. Antifactor Xa and heparin cofactor activity closely paralleled the At-
Autor:
Ole Rasmus Ødegård, Mette Lie
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 7:121-126
Methodological problems encountered using chromogenic substrates on thrombin and Xa are discussed: (1) influence of substrate on inhibitor; (2) influence of heparin; (3) optimal concentrations; (4) specificity; (5) denatured enzymes, and (6) natural
Autor:
Ole Rasmus Ødegård, Ulrich Abildgaard
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 7:127-134
Thrombin or factor Xa added to plasma are inactivated by antithrombin III (At-III). The inactivation is accelerated by heparin, permitting assay systems which rapidly measure the At-III content of diluted plasma. Without heparin, the slow inactivatio
Publikováno v:
Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology. 90(2)
Crude concentrates of extracellular proteases from strains belonging to species within the genus Legionella were examined for their effect upon synthetic chromogenic tri- and tetrapeptides. For the species L. pneumophila, similar and reproducible sub
Publikováno v:
Thrombosis research. 7(2)
Heparin coupled to albumin, ficoll and dextran by the CNBr method exerts anticoagulant and blood platelet aggretating effects which deviate from that of free heparin. Heparin-albumin complex had the same anticoagulant and aggregating effect as hepari